spacer
home > ict > autumn 2017 > handle with care
PUBLICATIONS
International Clinical Trials

Handle with Care

Catizone states, “When you are in the business of creating lifesaving drugs, the mundane detail of shipping logistics is not usually the first concern that springs to mind.

“The biopharmaceutical industry, by its very nature, is one in which underlying business operations are often perceived as secondary to the higher calling of treating or even curing some of the most devastating diseases on earth. But ensuring that clinical samples reach their destination safely, securely, and at the right temperature is just as crucial as any element of the drug discovery process (1).”

Medical laboratory and clinical personnel have always needed to transport biological samples from the patient source, between clinics and laboratories for centralised testing in clinical trials. However, a growing number of trial projects are now being performed on a global scale, with activity significantly increasing in developing countries, particularly Asian and Latin American locations (2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Fletcher is a BSc Hons graduate with a number of years’ experience working in research labs. Having attained the necessary standard on a Civil Aviation Authority-Approved course, Sue is certified in the Carriage of Diagnostic and Infectious Substances by Air and provides advice and training seminars across the country on UN3373 Dangerous Goods Packaging.
spacer
Sue Fletcher
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ChemAxon and AWS simplify getting scientists moving on the cloud

Listen to a talk by Paul Underwood of AWS introducing Biotech Blueprint, a cloud based solution for cheminformatics. The technology for novel compound registration is provided by ChemAxon.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

SAPHEX 2018

1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement